Cargando…
Intrastriatal transplantation of neurotrophic factor-secreting human mesenchymal stem cells improves motor function and extends survival in R6/2 transgenic mouse model for Huntington's disease
Stem cell-based treatment for Huntington's disease (HD) is an expanding field of research. Although various stem cells have been shown to be beneficial in vivo, no long standing clinical effect has been demonstrated. To address this issue, we are developing a stem cell-based therapy designed to...
Autores principales: | Sadan, Ofer, Melamed, Eldad, Offen, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3426086/ https://www.ncbi.nlm.nih.gov/pubmed/22953237 http://dx.doi.org/10.1371/4f7f6dc013d4e |
Ejemplares similares
-
Increased Body Weight of the BAC HD Transgenic Mouse Model of Huntington’s Disease Accounts for Some but Not All of the Observed HD-like Motor Deficits
por: Kudwa, Andrea E., et al.
Publicado: (2013) -
Dysfunctional mitochondrial respiration in the striatum of the Huntington’s disease transgenic R6/2 mouse model
por: Aidt, Frederik Heurlin, et al.
Publicado: (2013) -
Pitfalls in the detection of cholesterol in Huntington’s disease models
por: Marullo, Manuela, et al.
Publicado: (2012) -
High-Throughput Automated Phenotyping of Two Genetic Mouse Models of Huntington's Disease
por: Balci, Fuat, et al.
Publicado: (2013) -
Characterization of Striatal Neuronal Loss and Atrophy in the R6/2 Mouse Model of Huntington’s Disease
por: Dodds, Lindsay, et al.
Publicado: (2014)